Skip to main content
Published locations for PsA: Time to clinically meaningful response shorter with tofacitinib vs. placebo
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
PsA: Time to clinically meaningful response shorter with tofacitinib vs. placebo
User login
Username
Password
Reset your password
/content/psa-time-clinically-meaningful-response-shorter-tofacitinib-vs-placebo
/rheumatology/article/252116/psoriatic-arthritis/psa-time-clinically-meaningful-response-shorter
/psoriatic-arthritis-icymi/article/252116/psoriatic-arthritis/psa-time-clinically-meaningful-response